Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal)
Technology appraisal
Reference number: TA560
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.